InsidersTradesSigma
Explore the full record of transactions filed by MCDADE MARK, Director. Officer active across 1 company, notably Icosavax, Inc.. In total, 2 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €271k. History available since 1 April 2022. The latest transaction was disclosed on 10 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Mark McDade is a Director at Icosavax, Inc. As a board member, he is involved in the governance of the company and strategic decision-making. McDade has a strong background in the biopharmaceutical sector, enabling him to contribute to the organization's development.